반응 #68502

ord-5488d37a2b5d453ab57349912e78e4f6

반응 조건

상세 조건
See reaction.notes.procedure_details.

후처리

  1. 1
    기타A 48 mL sealed tube
  2. 2
    기타The tube was flushed with argon
  3. 3
    기타sealed
  4. 4
    기타placed in a 90° C.
  5. 5
    기타for 5 hours
  6. 6
    농축The mixture was concentrated
  7. 7
    기타the black solid was triturated with water
  8. 8
    기타to remove K2CO3
  9. 9
    기타purified by column chromatography
  10. 10
    세척eluting with 30-70% (90:10:1 DCM:MeOH:NH4OH solution) in DCM over 40 minutes
  11. 11
    기타Pure fractions were collected

실험 절차

A 48 mL sealed tube was charged with N-((6-chloro-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl)-7-methoxy-1,5-naphthyridin-4-amine (0.150 g, 0.439 mmol), 1H-pyrazol-4-ylboronic acid (0.0737 g, 0.658 mmol), and DMF (3.00 ml, 38.6 mmol). A solution of potassium carbonate (0.182 g, 1.32 mmol) and water (0.696 ml, 38.6 mmol) was added, followed by PdCl2(dppf)-CH2Cl2Adduct (0.0358 g, 0.0439 mmol). The tube was flushed with argon, sealed, then placed in a 90° C. oil bath for 5 hours. The mixture was concentrated and the black solid was triturated with water to remove K2CO3, then purified by column chromatography using a 40 g RediSep column, eluting with 30-70% (90:10:1 DCM:MeOH:NH4OH solution) in DCM over 40 minutes. Pure fractions were collected to give N-((6-(1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl)-7-methoxy-1,5-naphthyridin-4-amine as a white solid.

출처

DOI: 10.6084/m9.figshare.5104873.v1특허: US08524900B2uspto-grants-2013_09